IMMUNOHISTOCHEMISTRY IMMUNOHISTOCHEMISTRY LUNG PROFILE TAT BREAST CANCER PROFILE TAT TTF-1 (Thyroid Trans. Factor) 1 Day Triple-Negative Breast Cancer Panel 2 days Cytokeratin 5/6 1 Day Androgen Receptor Cal-Retinin 1 Day Cytokeratin 5/6 CD56, NK Cell 1 Day Cytokeratin 14 Cytokeratin-Pan 1 Day EGFR E. Cadherin LYMPHOMA PROFILE TAT P. Cadherin CD45 (LCA) 1 Day P53 CD20, B Cell 1 Day Ki67 CD3, T Cell 1 Day EPITHELIAL MARKERS TAT CD30 1 Day Alpha-Fetoprotein (AFP 2 days CD15 1 Day Cal-Retinin 1 Day CAM 5.2 1 Day MELANOMA PROFILE TAT CD15 1 Day S100 1 Day CDX2 1 Day Vimentin 1 Day CEA (Carcinoembryonic Antigen) 1 Day HMB45 1 Day Cytokeratin 5/6 1 Day MART-1 1 Day Cytokeratin 7 1 Day Melan A 1 Day Cytokeratin 19 1 Day Cytokeratin 20 1 Day Cytokeratin-HMW (CK-903) 1 Day UNDIFFERENTIATED TUMOR PROFILE TAT E-Cadherin 1 Day Cytokeratin-Pan 1 Day EGFR 1 Day Vimentin 1 Day EMA (Epithelial Membrane Antigen) 1 Day S100 1 Day HEPAR I 1 Day CD45 (LCA) 1 Day P63 1 Day SMA (Smooth Muscle Actin) 1 Day PLAP (Placental Alk. Phos.) 1 Day PSA (Prostate Spec. Antigen) 1 Day BREAST CANCER PROFILE TAT PSAP (Prostate Spec. Acid Phos.) 1 Day without Image Analysis 1 Day ER MESENCHYMAL MARKERS TAT PR CD34 1 Day HER2/Neu CD99 1 Day Ki67 CD117 (C-Kit) 1 Day P53 Nuclear Antigen Desmin 1 Day CD34 SMA (Smooth Muscle Actin) 1 Day DNA Ploidy SMM (Smooth Muscle Myosin) 1 Day with Image Analysis 2 Days Vimentin 1 Day IMMUNOHISTOCHEMISTRY FISH, CISH, MOLECULAR PROSTATE CANCER PROFILE TAT FLUORESCENT IN-SITU HYBRIDIZATION (FISH) TAT PSA (Prostate Spec. Antigen) 1 Day HER2/Neu by FISH 2-3 Days PSAP (Prostate Spec. Acid Phos.) 1 Day Kappa Light Chain (plasma cells) 2-3 Days Cytokeratin-HMW (CK-903) 1 Day Lambda Light Chain (plasma cells) 2-3 Days Racemase 1 Day t(11;14)(q13;q32) FISH (LSI IGH/CCND1 XT) 1-3 Days p63 1 Day t(14;18)(q32;q21) FISH (LSI IGH/BCL2) 1-3 Days PIN-4 1 Day MYC BAR FISH (LSI MYC DC BAR) 1-3 Days LEUKEMIA/LYMPHOMA TAT t(8;14)(q24;q32) FISH (IgH/MYC/CEP8) 1-3 Days ALK Protein (ALK-1) 2 Day t(9;22)(q34;q11.2) FISH (LSI BCR/ABL) 1-3 Days BCL-2 Oncoprotein 1 Day t(15;17)(q22;q21.1) FISH (LSI PML/RARA) 1-3 Days CD15 1 Day MDS Panel FISH 1-3 Days CD30 1 Day MM Panel FISH 1-3 Days CD45 (LCA) 1 Day MM Panel Extended FISH 1-3 Days CD10 (CALLA) 1 Day CLL Panel FISH 1-3 Days CD20 1 Day AML Panel FISH 1-3 Days CD23 1 Day ALL Panel FISH 1-3 Days CD 1A 1 Day UroVysion FISH (bladder cancer) 2-4 Days CD3 1 Day ImmunoCyt (IF) (bladder cancer) - non DNA FISH 2-4 Days CD5 1 Day TOP2A FISH (breast cancer) 2-3 Days CD34 1 Day PathVysion plus TOP2a FISH (breast cancer) 2-3 Days CD38 1 Day CD56 1 Day CD68, Macrophage 1 Day CHROMOGENIC IN-SITU HYBRIDIZATION (CISH) TAT CD138 1 Day HPV-high risk screen (Invader, Third-Wave) 1-2 Days Hemoglobin A 1 Day HPV type 16 (Invader, Third-Wave) 1-2 Days HPV type 18 (Invader, Third-Wave) 1-2 Days NEURAL/NEUROENDOCRINE PROFILE TAT Calcitonin 1 Day MOLECULAR TAT Synaptophysin 1 Day B-cell clonality, PCR/capillary electrophoresi 1-3 Days Chromogranin 1 Day T-cell clonality, PCR/capillary electrophoresis 1-3 Days CD56, NK Cell 1 Day BCR/ABL t(9;22) Qualitative - RT-PCR 1-3 Days NSE (Neuron Specific Enolase) 1 Day BCR/ABL t(9;22) Quantitative - Real Time RT-PCR 1-3 Days PML/RARA t(15;17) - RT-PCR 1-3 Days MISCELLANEOUS MARKERS TAT BCL-2/IgH t(14;18) Qualitative - PCR 1-3 Days HCG (Human Chorionic Gonadotropin) 2 Day JAK2 kinase V617F mutation-PCR/Restriction Digest 1-3 Days FLT3 mutation (ITD & D835) -PCR 1-3 Days INFECTIOUS AGENTS TAT GC/CT-GenProbe (NAAT Gen-Probe Aptima Combo2) 1-2 Day Helicobacter Pylori 1 Day MSI (PCR/capillary electrophoresis) 2-4 Days Human Papilloma Virus (HPV) 1 Day PCA3 (urine mRNA for prostate cancer-GenProbe) 1-2 Day FLOW CYTOMETRY/IMMUNOPHENOTYPING CYTOGENETICS LEUKEMIA TAT TAT Acute Myelogenous Leukemia (AML) 1 Day Chromosome Analysis 5 Days Chronic Myelogenous Leukemia (CML) 1 Day Trisomy 8 for Myeloid Disease Evaluation 5 Days Acute Lymphocytic Leukemia (ALL) 1 Day Trisomy 12 for CLL 5 Days Chronic Lymphocytic Leukemia (CLL) 1 Day Translocation (9:22) for CML 5 Days Hairycell Leukemia 1 Day Translocation (15:17) for APL 5 Days Translocation (11:14) for Mantle Cell Lymphoma 5 Days MYELOPROLIFERATIVE DISORDER TAT Translocation (14:18) for Follicular Lymphoma 5 Days Polycythemia Vera 1 Day CIRCULATING TUMOR CELL (CTC) TESTS Essential Thrombocythemia 1 Day TAT Idiopathic Myelofibrosis 1 Day Monitoring Test for Breast Cancer 1 Day LYMPHOMAS TAT Monitoring Test for Colorectal Cancer 1 Day B-cell Lymphomas 1 Day Monitoring Test for Prostate Cancer 1 Day T-cell Lymphomas 1 Day PLASMA CELL DISORDER TAT Plasma Cell Myeloma 1 Day Macroglobulinemia 1 Day Plasma Cell Leukemia 1 Day IMMUNE DISORDER TAT Immunodeficiency 1 Day T Helper / Suppressor Enumeration 1 Day Lymphocyte Subsets 1 Day
